The round was led by MassMutual Ventures with participation from Healthy Ventures and current investors. Co-founded by CEO Bill Gianoukos and Dr. Akl Fahed, a cardiologist at Massachusetts General Hospital and faculty member at Harvard Medical School, Goodpath will use the new funding to accelerate the expansion of its AI'driven, clinically'validated care model. The platform delivers integrative care across weight management, musculoskeletal (MSK) pain, sleep, digestive health, mental health, diabetes, and cancer survivorship in one seamless experience.

Goodpath delivers whole-person care for chronic conditions, including weight management, MSK pain, diabetes, digestive health, sleep, mental health, and cancer survivorship. Through clinical care, dedicated coaching, and a multi-disciplinary care team, Goodpath helps members address both symptoms and underlying drivers of health, including nutrition, movement, sleep, and mental well-being.